Biological Therapy Analysis & Statistics, September 2014

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: stem cell, cell therapy, tissue engineering, more »

1-30 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Tissue Engineering and Regeneration: Technologies and Global Markets

Tissue Engineering and Regeneration: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

This BCC Research report presents an in-depth analysis of the global tissue engineering and regeneration market by technologies, materials, applications segments and regional markets. It includes comprehensive ...

  • Industries : Biological Therapy
  • Countries : World
The Global Market for Stem Cells

The Global Market for Stem Cells

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research report provides detailed market, technology, and industry analyses to quantify and qualify the global market for prescription drug products. Important trends are identified and sales ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe, India, Canada, Germany, Japan, China, Brazil, Spain, Italy, France, Asia, Mexico, North America, United Kingdom
Induced Pluripotent Stem Cells : Global Markets

Induced Pluripotent Stem Cells : Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research report provides detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field ...

  • Industries : Biological Therapy
  • Countries : World, United States
Stem Cells -- 6 Dimensional Assessment (Technical Insights)

Stem Cells -- 6 Dimensional Assessment (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

The clinical translation of regenerative cells The scope of this research service comprises research within the area of adult and embryonic stem cells, and developments in the nascent area of induced pluripotent ...

  • Industries : Biological Therapy
Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry

Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital ...

  • Industries : Biological Therapy
  • Countries : World
Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

  • Industries : Biological Therapy
Immunotherapy in Oncology: Drug Pathway Analyzer 2014

Immunotherapy in Oncology: Drug Pathway Analyzer 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 811 immunotherapy drugs known to affect more than 234 specific intracellular signaling pathways for the ...

  • Industries : Biological Therapy
World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Critical Limb Ischemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Biological Therapy
  • Countries : World
Degenerative Disc Disease - Pipeline Review, H1 2014

Degenerative Disc Disease - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Degenerative Disc Disease - Pipeline Review, H1 2014', provides an overview of the Degenerative Disc Disease's therapeutic ...

  • Industries : Biological Therapy
  • Countries : World
Ophthalmics Partnering Terms & Agreements

Ophthalmics Partnering Terms & Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Opthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter opthalmics partnering deals. The majority of deals are discovery, preclinical ...

  • Industries : Biological Therapy
Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

There are today 120 companies plus partners developing 107 gene therapy drugs in 276 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

  • Industries : Biological Therapy
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 332 companies plus partners developing 441 Androgen Receptor drugs in 1457 developmental projects in cancer. ...

  • Industries : Biological Therapy
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...

  • Industries : Biological Therapy
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules. There are today 371 companies plus partners developing 642 EGFR1 pathway targeting drugs in 2397 developmental projects in cancer. ...

  • Industries : Biological Therapy
Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Aberrant activation of the Hedgehog pathway has been associated with a number of human malignancies including carcinoma of lung, esophagus, pancreas and prostate. There are today 119 companies plus partners ...

  • Industries : Biological Therapy
Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 252 companies plus partners ...

  • Industries : Biological Therapy
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor signaling. There are today 246 companies plus partners developing ...

  • Industries : Biological Therapy
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The TGF-beta receptor signaling pathway activates the MAPK/SMAD signaling modules. There are today 287 companies plus partners developing 411 TGF-beta receptor pathway targeting drugs in 1411 developmental ...

  • Industries : Biological Therapy
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The TNF-alfa signaling pathway stimulates the MAPK signaling module and activates NFkB. There are today 366 companies plus partners developing 550 TNF-alpha pathway targeting drugs in 2048 developmental ...

  • Industries : Biological Therapy
Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014

Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Abnormalities in the Wnt signaling pathway are associated with a large variety of human malignancies including tumors of breast, colon, pancreas, liver and bone. There are today 179 companies plus partners ...

  • Industries : Biological Therapy
Cancer Stem Cells Drug Pipeline Update 2014

Cancer Stem Cells Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which ...

  • Industries : Biological Therapy
Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, ...

  • Industries : Biological Therapy
International Stem Cell Corporation - Product Pipeline Review - 2014

International Stem Cell Corporation - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

International Stem Cell Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘International Stem Cell Corporation - Product Pipeline Review - 2014', provides an overview of the ...

  • Industries : Biological Therapy
  • Countries : World
Cell Therapy Deals and Alliances of 2013

Cell Therapy Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Cell Therapy Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Biological Therapy
 B-Cell Leukemia-Pipeline Insights, 2014

B-Cell Leukemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ B-Cell Leukemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Biological Therapy
 Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014

Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the ...

  • Industries : Biological Therapy
GM-CSF Inhibitors -Pipeline Insights, 2014

GM-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biological Therapy
Anti GM-CSF Antibody -Pipeline Insights, 2014

Anti GM-CSF Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti GM-CSF Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2014

Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Broad Spectrum Chemokine Inhibitors (BSCIs)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biological Therapy
B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2014

B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“B-Cell Activating Factor (BAFF) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biological Therapy

33 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

GlaxoSmithKline P.L.C.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.